Exocrine pancreatic insufficiency (EPI) is a syndrome characterized by insufficient synthesis of pancreatic enzymes leading to clinical symptoms of malabsorption and maldigestion. There are no studies about ultrasonographic appearance of the pancreas with EPI in dogs. The purpose of this...

The exocrine pancreatic insufficiency (EPI) in carnivores represents a syndrome characterized by the poor synthesis and/or secretion of digestive enzymes with acinar origin. The lack of pancreatic enzymes leads to the development of the maldigestion and malabsorption syndromes, responsible for most ...

Exocrine pancreatic insufficiency (EPI) is a functional disturbance resulting from a lack of pancreatic enzymes. This condition occurs less frequently compared to pancreatitis and is mainly caused by atrophy of pancreatic acinar cells, followed by the malabsorptionmaldigestion syndrome. Because of...

Background: Concurrent exocrine pancreatic dysfunction and decreased pancreatic organ size are common findings in various stages of human type 1 diabetes mellitus (DM). Exocrine pancreatic insufficiency (EPI) is incompletely described in diabetic dogs. Objective: To compare canine trypsin-like...

Exocrine pancreatic insufficiency (EPI) is a gastrointestinal disorder resulting from low secretion of digestive enzymes by the exocrine pancreas. The main clinical signs of EPI are: weight loss, polyphagia, increased fecal volume, diarrhea, steatorrhea and coprophagia. Dogs with EPI tend to...

Background: Recent studies have shown similar efficacy of oral supplementation of cobalamin compared to injectable supplementation in dogs, but few prospective, randomized studies have been published. Objectives: To evaluate efficacy of oral or injectable supplementation with cobalamin in...

An 8-month-old intact male Thai Bangkaew bred dog presented with polyuria, polydipsia, polyphagia, exercise intolerance and weight loss over 2 weeks. The serum biochemistry profiles revealed hyperglycemia, glycosuria and high serum fructosamineconcentrations indicating the development of diabetes...

Changes in proportions of lipoprotein classes have been described in disease states in humans. In veterinary medicine, hyperlipidemia can cause complications, such as cutaneous xanthomas, liver disease, cholelithiasis, pancreatitis, glomerular disease, lipemia retinalis, or peripheral neuropathy,...

This overview summarizes research performed during the last decades that has had an impact on the diagnosis and management of exocrine pancreatic insufficiency (EPI) in dogs. Pancreatic acinar atrophy is by far the most common cause for the maldigestion signs of canine EPI. The ability to diagnose ...

Background: Pancreatic enzyme supplements for the treatment of exocrine pancreatic insufficiency (EPI) in dogs can be uncoated or enteric coated. Enteric coated supplements might be advantageous. Hypothesis/Objectives: Enteric coated enzyme supplements are superior to uncoated supplements in dogs...